Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
PTGX Price/Volume Stats
| Current price | $55.23 | 52-week high | $60.60 |
| Prev. close | $53.00 | 52-week low | $32.50 |
| Day low | $53.13 | Volume | 796,458 |
| Day high | $55.41 | Avg. volume | 994,432 |
| 50-day MA | $49.93 | Dividend yield | N/A |
| 200-day MA | $44.86 | Market Cap | 3.42B |
PTGX Stock Price Chart Interactive Chart >
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
PTGX Price Returns
| 1-mo | -2.02% |
| 3-mo | 17.64% |
| 6-mo | 45.57% |
| 1-year | 52.91% |
| 3-year | 483.83% |
| 5-year | 225.55% |
| YTD | 43.08% |
| 2024 | 68.34% |
| 2023 | 110.17% |
| 2022 | -68.10% |
| 2021 | 69.64% |
| 2020 | 185.96% |
Loading social stream, please wait...